Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129099) titled 'Predicting Heart Failure Risk in Hypertrophic Cardiomyopathy Using Genetic and Digital Health Data' on July 31.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Peking Union Medical College Hospital

Condition: Hypertrophic cardiomyopathy (HCM)

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-08-01

Target Sample Size: HCM cohort (single-arm):200;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=334047

Published by HT Digital Content Services with permission from Health Daily Digest....